Immune surveillance system: its failure and activation.
D000368:Aged; D000818:Animals; D000906:Antibodies; D001943:Breast Neoplasms / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D003165:Complement System Proteins; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000276:immunology; D007951:Leukemia, Myeloid / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D008748:Methylcholanthrene; D009369:Neoplasms / Q000139:chemically induced / Q000150:complications / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology; D013997:Time Factors; D014412:Tumor Virus Infections / Q000276:immunology
D000906:Antibodies; D007166:Immunosuppressive Agents; D008748:Methylcholanthrene; D003165:Complement System Proteins